DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.
Also called NCT03494920
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 295 participants
- Registry
-
NCT03494920
-
- Other papers using this trial's data
- Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, China, Singapore, Vietnam
- Registry status
- Completed
Technical summary
Registry record NCT03494920. Randomized; single masking; primary purpose treatment. Start 2018-04-27 (actual); primary completion 2021-09-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
- Condition
- Ischemic Stroke
- Intervention (Other)
- Direct endovascular clot retrieval
- Intervention (Other)
- Bridging thrombolysis followed by ECR
- Lead sponsor
- Neuroscience Trials Australia
- Collaborator
- The Florey Institute of Neuroscience and Mental Health
Record details
- Record id
cardio:ct-nct03494920- Content hash
7afbd12f10574b625d36303328af23b28158eb5af211e22cba675b8d974f402f